Deerfield Management Company, L.P. (Series C) Aclaris Therapeutics, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $3.15 Million - $9.84 Million	-3,983,025 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $4.07 Million - $13.5 Million	-1,910,391 Reduced 32.42%	3,983,025 $8.72 Million
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $17.6 Million - $43.1 Million	2,800,000 Added 90.51%	5,893,416 $43.6 Million
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $5 Million - $7.26 Million	347,711 Added 12.66%	3,093,416 $44.9 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $8.75 Million - $13.1 Million	512,289 Added 22.94%	2,745,705 $48.1 Million
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $14.1 Million - $18.2 Million	655,489 Added 41.54%	2,233,416 $55.1 Million
Q3 2017 Nov 13, 2017	BUY	$23.02 - $28.8 $36.3 Million - $45.4 Million	1,577,927	1,577,927 $40.7 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$58 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$19.1 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$13.7 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$12.2 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$11.2 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account